Home › Funds › LGL PARTNERS, LLC › PTCT

LGL PARTNERS, LLC position in PTCT

PTC THERAPEUTICS INC · Health Care

LGL PARTNERS, LLC reported holding 9,000 shares of PTCT (PTC THERAPEUTICS INC) in its Q2 2026 13F filing — a position valued at US$734K, representing 0.27% of its reported portfolio and ranking #29 among its reported holdings. LGL PARTNERS, LLC has disclosed PTCT holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

Latest position (Q2 2026)9.00K sh
Reported value held$734.13K
Portfolio Weight0.27%
First reportedQ2 2024
Last changeHold
Updated2026-10-24

Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR

How LGL PARTNERS, LLC's PTCT position evolved

LGL PARTNERS, LLC first disclosed a stake in PTCT in Q2 2024 at 12,000 shares (US$367K). The position peaked in Q3 2025 at 17,067 shares, worth US$1.0M. Across 9 filings, LGL PARTNERS, LLC increased the stake 2 time(s), trimmed it 1 time(s) and left it unchanged 5 time(s). The most recent filing (Q2 2026) shows 9,000 shares valued at US$734K. Notable position changes include a 33% increase in Q2 2025 (shares rose 26% over the following quarter), a 47% trim in Q4 2025 (shares fell 10% over the following quarter).

Quarter by quarter

QuarterSharesValueChange
Q2 2024 12.00K $366.96K New
Q3 2024 12.01K $445.57K Hold
Q4 2024 12.02K $542.40K Hold
Q1 2025 12.00K $611.52K Hold
Q2 2025 16.00K $805.76K Add
Q3 2025 17.07K $1.05M Add
Q4 2025 9.00K $683.64K Reduce
Q1 2026 9.00K $613.17K Hold
Q2 2026 9.00K $734.13K Hold

Dots on the line are colored by change type; missing quarters mean no position was reported.

About PTCT and 13F data

PTCT (PTC THERAPEUTICS INC) is a Health Care company. 55 other funds we track also report a position in PTCT — the largest reported positions include RTW INVESTMENTS, LP (US$631.9M), TORONTO DOMINION BANK (US$176.7M), WESTFIELD CAPITAL MANAGEMENT CO LP (US$159.6M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.

Other funds holding PTCT

All PTCT fund holders →

FAQ

How long has LGL PARTNERS, LLC held PTCT?

LGL PARTNERS, LLC has disclosed PTCT holdings in 9 of the last 9 reported quarters, going back to Q2 2024.

What is LGL PARTNERS, LLC's current position in PTCT?

As of Q2 2026, LGL PARTNERS, LLC holds 9.00K shares of PTCT (PTC THERAPEUTICS INC), valued at $734.13K, representing 0.27% of its reported portfolio and ranking #29.

Has LGL PARTNERS, LLC been buying or selling PTCT?

In the latest 13F filing (Q2 2026), LGL PARTNERS, LLC held unchanged its position in PTCT. The position peaked in Q3 2025 at 17.07K shares.

Which other funds hold PTCT?

Other major institutional holders of PTCT include RTW INVESTMENTS, LP, TORONTO DOMINION BANK, WESTFIELD CAPITAL MANAGEMENT CO LP, among 55 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.